Patent · US Active

Morphine formulations

US9072781B2 · kind B2 · utility

6Cited by

35References

42Claims

0Family size

Assignee

Becton Dickinson France · FR

Inventors

Alain Cuine · Saint-Jean-de-Braye, FR
Didier Hoarau · Le Pont-de-Claix, FR
Pauline ROMAIN · Yssingeaux, FR

Key dates

Filing date	Mar 12, 2014
Grant date	Jul 7, 2015
Priority date	—
Expiry date	Mar 12, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein, generally, are pharmaceutical formulations, e.g., injectable pharmaceutical formulations with improved stability, comprising morphine sulfate or a hydrate thereof, and methods of producing and using the same. Also provided herein are kits comprising the formulations, e.g., injectable morphine formulations.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.